Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,735,260 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
| Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | 0.10% | 2.57% | -1.73% | -2.72% | 23.89% | 24.55% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 258 | 332,071 | 0.43% | 4.30% | -2.68% | -4.02% | 2.26% | -13.58% |
| Oncology Biopharmaceuticals | ONCOLOGY | SubInd | 199 | 182,969 | 0.96% | 3.46% | -6.32% | -1.54% | 10.75% | -4.51% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | JANX:USAJANX:USA | Stock | 1 | 2,996 | 3.76% | 36.70% | 82.99% | 645.45% | 889.01% | 339.19% |
| Cullinan Therapeutics, Inc. | CGEM:USACGEM:USA | Stock | 1 | 1,216 | 2.79% | 12.06% | 69.96% | 57.50% | 201.60% | 195.31% |
| Deciphera Pharmaceuticals, Inc. | DCPH:USADCPH:USA | Stock | 1 | 2,043 | 0.00% | 73.24% | 67.64% | 71.95% | 116.18% | 91.11% |
| ALX Oncology Holdings, Inc. | ALXO:USAALXO:USA | Stock | 1 | 767 | -7.58% | -8.90% | 36.65% | -1.85% | 99.48% | 141.89% |
| Revolution Medicines, Inc. | RVMD:USARVMD:USA | Stock | 1 | 6,620 | 2.58% | 11.79% | 33.38% | 33.60% | 90.07% | 65.91% |
| AnaptysBio, Inc. | ANAB:USAANAB:USA | Stock | 1 | 707 | 0.91% | 26.57% | 24.79% | 10.43% | 64.07% | 26.21% |
| Summit Therapeutics, Inc. | SMMT:USASMMT:USA | Stock | 1 | 3,082 | 8.13% | 13.73% | 24.01% | 14.32% | 119.50% | 149.43% |
| Enliven Therapeutics, Inc. | ELVN:USAELVN:USA | Stock | 1 | 935 | 7.91% | 31.84% | 21.77% | 53.56% | 85.81% | 21.25% |
| Day One Biopharmaceuticals, Inc. | DAWN:USADAWN:USA | Stock | 1 | 1,498 | -2.28% | 15.08% | 20.92% | 14.39% | 42.85% | 26.44% |
| Y-mAbs Therapeutics, Inc. | YMAB:USAYMAB:USA | Stock | 1 | 749 | -0.58% | 16.59% | 17.79% | 25.46% | 222.67% | 177.51% |
| Shattuck Labs, Inc. | STTK:USASTTK:USA | Stock | 1 | 512 | -2.88% | 1.79% | 16.16% | 10.91% | 557.32% | 285.00% |
| Lyell Immunopharma, Inc. | LYEL:USALYEL:USA | Stock | 1 | 599 | -1.67% | 8.76% | 12.92% | 32.58% | 18.00% | -2.48% |
| Xencor, Inc. | XNCR:USAXNCR:USA | Stock | 1 | 1,471 | 2.03% | 20.67% | 12.82% | 28.31% | 37.85% | -12.77% |
| Cogent Biosciences, Inc. | COGT:USACOGT:USA | Stock | 1 | 649 | 3.29% | 25.08% | 9.13% | 32.11% | -12.03% | -33.66% |
| Merus NV | MRUS:USAMRUS:USA | Stock | 1 | 2,796 | 1.81% | 7.37% | 8.55% | 33.63% | 120.42% | 157.10% |
| IDEAYA Biosciences, Inc. | IDYA:USAIDYA:USA | Stock | 1 | 2,743 | 1.66% | 5.61% | 1.88% | -3.23% | 42.16% | 122.00% |
| Olema Pharmaceuticals, Inc. | OLMA:USAOLMA:USA | Stock | 1 | 587 | 5.96% | 7.24% | 1.52% | -29.10% | -32.21% | 68.03% |
| Kura Oncology, Inc. | KURA:USAKURA:USA | Stock | 1 | 1,572 | 0.19% | 4.99% | 1.33% | 0.39% | 145.01% | 84.03% |
| Relay Therapeutics, Inc. | RLAY:USARLAY:USA | Stock | 1 | 931 | -0.56% | 10.52% | 1.15% | -18.99% | -4.86% | -37.25% |
| Immatics NV | IMTX:USAIMTX:USA | Stock | 1 | 912 | -1.10% | 7.59% | 0.56% | -4.94% | 31.66% | 11.26% |
| Halozyme Therapeutics, Inc. | HALO:USAHALO:USA | Stock | 1 | 5,059 | 0.23% | 3.47% | 0.45% | 18.50% | 16.53% | 29.28% |
| Iovance Biotherapeutics, Inc. | IOVA:USAIOVA:USA | Stock | 1 | 3,491 | 5.82% | 17.10% | 0.22% | 72.10% | 251.29% | 98.98% |
| Fusion Pharmaceuticals, Inc. | FUSN:USAFUSN:USA | Stock | 1 | 1,710 | -0.19% | 0.14% | 0.09% | 102.55% | 371.43% | 425.74% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,779 | 75,176,635 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
| Tyra Biosciences, Inc. | TYRA:USATYRA:USA | Stock | 1 | 768 | -3.67% | 13.91% | -0.83% | 3.48% | 40.00% | 39.67% |
| BridgeBio Pharma, Inc. | BBIO:USABBIO:USA | Stock | 1 | 5,208 | 0.32% | 11.86% | -1.14% | -17.25% | 3.38% | 106.15% |
| Nuvalent, Inc. | NUVL:USANUVL:USA | Stock | 1 | 4,507 | -2.95% | 5.22% | -2.16% | -10.26% | 27.65% | 81.78% |
| Syndax Pharmaceuticals, Inc. | SNDX:USASNDX:USA | Stock | 1 | 1,870 | 0.87% | 4.70% | -2.52% | 3.57% | 49.19% | 9.81% |
| CG Oncology, Inc. | CGON:USACGON:USA | Stock | 1 | 2,417 | -8.18% | -11.54% | -3.92% | -3.07% | N/A | N/A |
| Cargo Therapeutics, Inc. | CRGX:USACRGX:USA | Stock | 1 | 838 | -3.01% | 8.83% | -4.42% | -7.80% | N/A | N/A |
| Zymeworks, Inc. | ZYME:USAZYME:USA | Stock | 1 | 655 | 2.22% | 11.38% | -4.76% | -15.98% | 30.50% | 8.36% |
| Arrivent BioPharma, Inc. | AVBP:USAAVBP:USA | Stock | 1 | 577 | 2.56% | 11.59% | -5.85% | -19.93% | N/A | N/A |
| Oncology Biopharmaceuticals | ONCOLOGY | SubInd | 199 | 182,969 | 0.96% | 3.46% | -6.32% | -1.54% | 10.75% | -4.51% |
| Exelixis, Inc. | EXEL:USAEXEL:USA | Stock | 1 | 6,461 | -0.99% | -7.59% | -6.77% | 2.34% | 8.79% | 12.42% |
| Nuvation Bio, Inc. | NUVB:USANUVB:USA | Stock | 1 | 705 | -1.53% | 20.15% | -7.47% | 105.10% | 151.56% | 98.77% |
| Arcus Biosciences, Inc. | RCUS:USARCUS:USA | Stock | 1 | 1,185 | 1.29% | 0.96% | -9.09% | 3.15% | -0.32% | -19.45% |
| MacroGenics, Inc. | MGNX:USAMGNX:USA | Stock | 1 | 973 | 2.96% | 7.62% | -11.87% | -6.45% | 206.65% | 119.47% |
| OmniAb, Inc. | OABI:USAOABI:USA | Stock | 1 | 546 | 1.52% | 4.24% | -12.71% | -17.49% | 2.19% | 35.76% |
| Oric Pharmaceuticals, Inc. | ORIC:USAORIC:USA | Stock | 1 | 533 | 2.00% | 20.32% | -13.23% | -15.42% | 43.85% | 96.16% |
| Arvinas, Inc. | ARVN:USAARVN:USA | Stock | 1 | 2,232 | 1.20% | 1.39% | -13.40% | -29.11% | 102.47% | 39.60% |
| Bristol Myers Squibb Co. | BMY:USABMY:USA | Stock | 1 | 89,168 | 0.66% | -1.92% | -14.42% | -7.25% | -11.95% | -31.34% |
| Arcellx, Inc. | ACLX:USAACLX:USA | Stock | 1 | 2,755 | -1.13% | 1.48% | -15.03% | -20.73% | 29.24% | 21.80% |
| Northwest Biotherapeutics, Inc. | NWBO:USANWBO:USA | Stock | 1 | 541 | -1.27% | -5.15% | -15.63% | -19.30% | -43.90% | -24.34% |
| Immunome, Inc. | IMNM:USAIMNM:USA | Stock | 1 | 681 | 5.21% | 14.71% | -22.26% | -6.69% | 80.83% | 179.75% |
| Zentalis Pharmaceuticals, Inc. | ZNTL:USAZNTL:USA | Stock | 1 | 829 | 5.40% | 5.88% | -23.56% | 3.08% | -29.46% | -46.72% |
| Allogene Therapeutics, Inc. | ALLO:USAALLO:USA | Stock | 1 | 516 | 3.37% | 6.23% | -24.20% | -25.85% | 3.37% | -52.40% |
* Colors indicate performance relative to the benchmark.